This was stated yesterday Friday, the Head of Medical Oncology Department at the Pierre and Marie Curie Center (CPMC) of Algiers, Pr. Kamel Bouzid, on the sidelines of the 2nd Congress on Medical Oncology of two days.
the acquisition of these innovative drugs for the treatment of cancer "have proved their effectiveness in the countries that have used them," he assured.
Patients undergoing treatment in hospitals and cancer centers will benefit from these drugs because of their "high cost and non-reimbursement by the Social Security Funds", according to Pr. Bouzid.